Alain Astier - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Alain Astier's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Alain Astier
Verified
Editor-in-Chief, Annales Pharmaceutiques Françaises
Paris
Beats
and healthcare cancer medicinei cover health
Content
By Alain Astier Verified| Hospital Healthcare Europe Verified Dosing anticancer drugs by body surface area was first introduced in the 1950s, based on preclinical animal models. The rationale was that this metric would better correlate with drug pharmacokinetics and organ function than weight-based dosing. But is it still appropriate in oncology practice today? Professor Alain Astier explains.
By Alain Astier Verified, Helena Beer Verified| Hospital Pharmacy Europe Verified Dosing anticancer drugs by body surface area was first introduced in the 1950s, based on preclinical animal models. The rationale was that this metric would better correlate with drug pharmacokinetics and organ function than weight-based dosing. But is it still appropriate in oncology practice today? Professor Alain Astier explains.
By Alain Astier Verified| Hospital Healthcare Europe Verified Dosing anticancer drugs by body surface area was first introduced in the 1950s, based on preclinical animal models. The rationale was that this metric would better correlate with drug pharmacokinetics and organ function than weight-based dosing. But is it still appropriate in oncology practice today? Professor Alain Astier explains.
Company Info
Annales Pharmaceutiques Françaises